Total Funding
19
34
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
174164
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body.
Gail K. Naughton: Founder and Scientific Advisor
Richard Pascoe: President & Chief Executive OfficerPast Role: King Pharmaceuticals, Senior Vice President
About the Company
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body. The company’s innovative technology platform utilizes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address underserved,
multi-billion US dollar global markets.
It was founded in 2007 by Dr. Gail Naughton and is headquartered in San Diego, California.
Women Founded
